WVE
Wave Life Sciences, Inc.
+0.07 (+1.44%)4.58USD587K成交股數902M市值–本益比(近四季)13.8股價營收比-73.9%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.3M-74% | 38.2M+317% | – | – | 8.7M-31% | 9.2M-68% | – | 19.7M-11% | 12.5M | 29.1M | 49.2M | 22.1M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 51.3M | 47.4M | 52.8M | 45.9M | 43.5M | 40.6M | 41.2M | 40.4M | 33.4M | 34.1M | 31.6M | 33.3M |
| 銷售管理費用 | 24.8M | 22.1M | 20.9M | 18.1M | 18.0M | 18.4M | 15.0M | 14.3M | 13.5M | 13.7M | 13.1M | 12.3M |
| 營業利益 | −73.8M+40% | −31.3M-37% | −56.5M-12% | −56.4M+61% | −52.8M+53% | −49.8M+167% | −63.9M-1538% | −35.0M+49% | −34.5M | −18.7M | 4.4M | −23.5M |
| 營業利益率 | -3,248.3% | -81.8% | – | – | -606.5% | -542.8% | – | -177.7% | -274.8% | -64.3% | 9.0% | -106.2% |
| 稅後淨利 | −69.4M+37% | −26.1M-44% | −53.2M-14% | −53.9M+64% | −50.5M+60% | −46.9M+188% | −61.8M-952% | −32.9M+56% | −31.6M | −16.3M | 7.3M | −21.1M |
| 淨利率 | -3,052.6% | -68.2% | – | – | -580.2% | -510.9% | – | -167.2% | -251.7% | -55.9% | 14.7% | -95.5% |
| 稀釋 EPS | -0.34+10% | -0.13-55% | -0.29-38% | -0.32+28% | -0.31+29% | -0.29+107% | -0.47-771% | -0.25+25% | -0.24 | -0.14 | 0.07 | -0.20 |
| 稀釋股數 | 204M | 200M | 169M | 168M | 164M | 163M | 133M | 130M | 129M | 106M | 107M | 105M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 368M | 545M | 602M | 196M | 208M | 243M | 311M | 154M | 181M | 200M | 140M | 173M |
| 應收帳款 | 888K | 0.00 | 1.3M | 10.0M | 1.6M | – | 0.00 | 1.3M | 0.00 | 21.1M | 7.0M | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 558M | 584M | 638M | 241M | 252M | 288M | 359M | 209M | 235M | 275M | 200M | 230M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 105M | 71.8M | 112M | 109M | 105M | 109M | 209M | 204M | 202M | 227M | 233M | 274M |
| 股東權益 | 454M | 512M | 518M | 125M | 139M | 172M | 142M | −3.5M | 25.4M | 39.6M | −40.5M | −51.7M |
| 負債比 | 18.8% | 12.3% | 17.6% | 45.1% | 41.7% | 37.7% | 58.3% | 97.9% | 85.9% | 82.7% | 116.3% | 119.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −59.6M-6% | – | – | – | −63.0M | – | – | −33.4M | – | – | – |
| 資本支出 | – | 438K | – | – | – | 165K | – | – | 417K | – | – | – |
| 自由現金流 | – | −60.0M-5% | – | – | – | −63.2M | – | – | −33.8M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -156.9% | – | – | – | -688.9% | – | – | -270.0% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 42.7M | -60.5% | −204M | -478.3% | -1.21 | −188M |
| FY2024 | 108M | -4.4% | −97.0M | -89.6% | -0.70 | −152M |
| FY2023 | 113M | +3005.1% | −57.5M | -50.8% | -0.54 | −20.5M |
| FY2022 | 3.6M | -91.1% | −162M | -4,434.7% | -2.05 | −129M |
| FY2021 | 41.0M | +104.0% | −122M | -298.4% | -2.36 | −89.6M |
| FY2020 | 20.1M | +25.6% | −150M | -746.7% | -3.82 | −117M |
| FY2019 | 16.0M | +10.9% | −194M | -1,211.5% | -5.72 | −192M |
| FY2018 | 14.4M | – | −147M | -1,017.4% | -5.06 | −32.8M |